Viking Therapeutics Shares Rise as Weight Loss Drug’s Potential May Exceed Initial Expectations Aug 28, 2025 Life Science
AbbVie Places $1.2 Billion Bet on Next-Generation “Non-Hallucinogenic” Psychedelic Drug Aug 25, 2025 Life Science
Intuitive Surgical Stock: Priced for Perfection, But Is It Still a Long-Term Buy? Aug 25, 2025 Life Science, Technology
Meet Tomorrow’s Needs – Invest in the Healthcare Revolutionaries at GCFF on Jun 16, 2022 May 26, 2022 Life Science
RepliCel Ships DermaPrecise(TM) Injector Prototypes and Consumables to Independent Laboratory for Clinical Simulation Testing Nov 11, 2021 Life Science
RepliCel’s Clinical Advisory Team Delivers Skin Rejuvenation Clinical Study Synopsis to its Japanese Regulatory and Clinical Study Management Team Nov 9, 2021 Life Science
RepliCel Files Notice of Arbitration against Shiseido Company to Resolve its License Agreement Dispute Regarding its Androgenetic Alopecia Cell Therapy Oct 18, 2021 Life Science
RepliCel Life Sciences Appoints One of Japan’s Foremost Regenerative Medicine Industry Business Leaders as Strategic Advisor Oct 12, 2021 Life Science
Insights into China’s Pharmaceutical Industry Trends from a 2,000-strong Industry Conference Sep 30, 2021 Life Science
RepliCel and University of Victoria Collaboration Leads to Bioengineering Innovations, Funding, and Patents Sep 16, 2021 Life Science
RepliCel Applies for Manufacturing Approval for its Collagen and Tissue Regeneration Cell Therapies Jul 7, 2021 Life Science
